Added to YB: 2025-12-23
Pitch date: 2025-12-20
INDGN.NS [neutral]
Indegene Limited
+12%
current return
Author Info
No bio for this author
Company Info
Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, North America, and internationally.
Market Cap
INR 141.2B
Pitch Price
INR 527.88
Price Target
N/A
Dividend
0.38%
EV/EBITDA
20.34
P/E
35.29
EV/Sales
3.36
Sector
Life Sciences Tools and Services
Category
growth
Indegene Limited – Should it go into a 'Too Hard' Pile or can fit in a tracking position?
INDGN.NS (overview): Life sciences commercialization co helping pharma digitize sales/marketing ops. All top 20 pharma clients, minimal churn. Revenue $10M→$320M (25% CAGR). Debt-free, $200M cash, 12-13% net margins. AI tailwinds, patent cliffs driving growth. Risk: client budget cyclicality, acquisition integration.
Read full article (8 min)